In contrast, cancers such as chronic myeloid leukemia and prostate cancer can be stratified by a cancer type-specific fusion such as BCR-ABL and TMPRSS2-ERG respectively [3]. This evidence concerns the gene TMPRSS2 and chronic myelogenous leukemia, BCR-ABL1 positive.